Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 140.00
Ask: 160.00
Change: 5.00 (3.45%)
Spread: 20.00 (14.286%)
Open: 150.00
High: 150.00
Low: 150.00
Prev. Close: 145.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Churchill China Sales Hit By Virus

Thu, 11th Jun 2020 13:23

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Thursday and not separately reported by Alliance News:

----------

Churchill China PLC - Stoke-on-Trent-based ceramic products maker - Virus impacts sales to hospitality markets significantly. Following a strong start to 2020, trading in April and May well below normal levels. Several actions taken to mitigate the effect of reduction in activity. Seeing first signs of an improvement in trading with growing levels of orders and activity. Anticipates increased market demand over the next few months. Overall monthly revenue to remain below 2019 levels for some time as hospitality market activity re-adjusts. Consulting with employees in relation to the potential reduction in the size of workforce. No decision yet been made on the number of redundancies.

----------

Princess Private Equity Holding Ltd - Guernsey-based investment company - Completes stake sale in non-food discount retailer Action. Received initial proceeds of EUR80.9 million following the closing. Transaction involves deferred proceeds of EUR9.1 million. Stake sale has no impact on net asset value. Cash position following the stake sale stands at EUR107.0 million.

----------

Secure Property Development & Investment PLC - County Durham, England-based eastern Europe focused property investor - Gets three month extension to publish 2019 results. Confident that 2020 results will not suffer any material adverse effects from the coronavirus pandemic crisis. 2019 results to be in line with management expectations with 18% year-on-year rise in rental income to EUR2.1 million.

----------

Agronomics Lted - Isle of Man-based biotechnology investor - Invests EUR1 million in Dutch cultivated meat company Meatable BV. Buys 997 preferred shares in Meatable's Seed 2 financing. Will ultimately own a 6.5% stake in Meatable following conversion of a EUR2 million loan note.

----------

REA Holdings PLC - London-based palm oil producer focused on Indonesia - Production in the first few months of 2020 at good levels. With many harvesters unable to travel home for the traditional Ramadan holiday, productivity has been maintained. Crude palm oil production for the year to May 31 increased 5.1% year-on-year to 83,400 tonnes. Crude palm kernel oil production up 20% at 5,400 tonnes. Fresh fruit bunch harvest increases 4.8% to 370,000 tonnes. Crude palm oil prices fell to USD510 per tonne in mid-May from USD860 on January 1. Since then, prices have recovered moderately to current level USD595 per tonne. Taking steps to reduce costs including cutting 200 staff, mostly temporary workforce.

----------

ADES International Holding PLC - UAE-based oil & gas drilling services provider - Sees 22% year-on-year jump in revenue for the three months to March 31. April saw continuation of first-quarter revenue trends. Utilisation rate 96% versus 92%. Margins broadly in line with 2019. Order backlog at USD1.34 billion at end of first-quarter versus USD1.31 billion at 2019-end. Net debt of USD640.3 million as at March 31. Continues to expect a similar earnings before interest, tax, depreciation and amortisation performance for 2020 to that achieved in 2019. Anticipates modest reduction in utilisation rates in 2020 due to the oil price volatility.

----------

Anglo African Oil & Gas PLC - London-based cash shell - Secures GBP1.5 million unsecured convertible loan from Riverfort Global Opportunities PCC Ltd. Each drawdown is interest free but attracts a 7% drawdown fee to be added to the principal amount outstanding and convertible on the same terms. All drawdowns and fees associated with them will be convertible into ordinary shares.

----------

Ironveld PLC - Cardiff, Wales-based iron miner focused on South Africa - Applies for ZAR240 million, around GBP11.3 million, project development funding to a major South African lender for commencing mining and production at magnetite project. Partner Inclusive Investment Group Proprietary Ltd agrees to provide a bridge funding facility of up to ZAR3.70 million. Extends option pact for Inclusive Investment to buy 440.2 million Ironveld shares at 0.42 pence per share. The option was to expire on Wednesday next week.

----------

Faron Pharmaceuticals Oy - Finland-based drug discovery company - Selected to receive a EUR2.5 million grant from the European Innovation Council Accelerator pilot scheme to progress the Matins study and related business activities. Matins clinical trial is investigating the tolerability, safety and efficacy of Clevegen, Faron's novel precision cancer immunotherapy targeting Clever-1 positive tumour associated macrophages in selected metastatic or inoperable solid tumours.

----------

Cohort PLC - Reading, England-based defence technology provider - Subsidiary Chess Dynamics awarded a EUR7.5 million contract for its Air Guard Counter-Unmanned Aerial Systems for air base and critical infrastructure protection for an international customer. Majority of the contract to be delivered during the current and next financial years. Contract further underpins group revenue and short and medium term outlook.

----------

Amur Minerals Corp - Khabarovsk, Russia-based minerals explorer - Receives non-binding indicative offtake terms for both the nickel and copper concentrates from Kun-Manie project in Russia. Gipronickel Institute conducting metallurgical testwork programme on Kun-Manie.

----------

Europa Oil & Gas Holdings PLC - London-based oil & gas explorer - Acquiring 100% interest in Frontier Exploration Licence 3/19, offshore Ireland, from DNO for a nominal upfront fee and the granting of a 5% net profits interest over future production of gas and liquids from any accumulation on FEL 3/19 to DNO. Licence will add 1.2 trillion cubic feet of gas to Europa's inventory in Ireland.

----------

Greatland Gold PLC - London-based precious metals explorer - Reports exceptional drill results from Havieron deposit in the Paterson region of Western Australia. Results demonstrate improved continuity in the high-grade crescent sulphide zone and extend the strike length of mineralisation to 550 metres in the upper 200 metres of that zone. Drilling has also provided further confirmation of the potential for a bulk tonnage target in the adjacent breccia hosted mineralisation. Farm-in partner Newcrest Mining Ltd planning further 80,000 metres of drilling at Havieron over the next 12 months.

----------

Ariana Resources PLC - London-based gold explorer - Reports 50% rise in resource estimate for Tavsan project in Turkey to 4.49 million tonnes for 253,000 ounces of gold and 723,000 ounces of silver. Estimate further de-risked with 77% of the resource now in the measured and indicated JORC categories. Discussions with potential lenders to commence imminently to secure funding for the development of the project. Tavsan is part of the Red Rabbit Joint Venture with Proccea Construction Co and is 50% owned by Ariana.

----------

MetalNRG PLC - London-based natural resources investor - Identifies a number of onshore oil & gas assets in the UK. Enters into preliminary agreement with the owners of a small portfolio of onshore, conventional, oil & gas producing licences. Finalising the required funding for the acquisition. Working on development plans for its Gold Ridge gold mine in the US state of Arizona, which will help minimise risk and create a sustainable path to revenues from the waste resources left behind from previous operators and resource from new unexplored areas. Proposes alternative commercial terms to vendor for the potential oil & gas acquisition in Romania.

----------

Open Orphan PLC - London-based pharmaceutical services provider - Unit Venn Life Sciences signs a major contract with a leading vaccine developer and one of the top pharmaceutical companies in the world. Contract is to obtain and support market access of newly developed vaccines into the EU and US markets until the end of 2020.

----------

Inspiration Healthcare Group PLC - Crawley, West Sussex-based medical technology supplier - Gets grant award for Project Wave which is developing a novel technology for a respiratory device designed to be used in neonatal intensive care. Grant towards the cost of trials expected to commence this year on 20 babies at Trevor Mann Unit, Brighton & Sussex University Hospital. Med Tech Trials Innovation Support Grant awarded by the Academic Health Science Networks and part financed by the European Regional Development Fund, which will contribute up to 50%, or GBP50,000 maximum, towards the costs of the trials.

----------

Woodbois Ltd - London-headquartered forestry and agriculture company - To recommence limited operations in Gabon next week. Seeing gradual increase in trading enquiries. Enquiries and demand levels, particularly from Asia and the Middle East, have started to return. Zahid Abbas and Jacob Hansen have stepped down from board but will remain as head of trading and chief operating officer respectively. In talks to restructure unlisted debt instruments to strengthen financial position.

----------

STV Group PLC - Scottish broadcaster - Agrees a deal with Virgin Media which will enable its TV customers across the UK to watch the STV Player via their set top box. STV Player app and catch-up service was integrated into Virgin Media's set top boxes for viewers in Scotland in December 2018. This new deal ensures that STV content can now be accessed throughout the UK, considerably extending the reach of the STV Player.

----------

Matomy Media Group Ltd - Tel Aviv-Yafo, Israel-based cash shell - Shares to be suspended from the London Stock Exchange's main market on June 23. Shares will continue trading on the Tel Aviv Stock Exchange. Matomy continues to consider its options and scouting for new opportunities going forward.

----------

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
6 Nov 2023 10:31

Faron reveals details of next stage of bexmarilimab study

(Sharecast News) - Faron Pharmaceuticals announced on Monday that, following guidance from the US Food and Drug Administration (FDA), the initial indication for phase two advancement in the study investigating bexmarilimab in combination with standard of care, would focus on hypomethylating agents (HMAs)-refractory or relapsed myelodysplastic syndromes (MDS).

Read more
30 Oct 2023 15:56

TRADING UPDATES: Bezant optimistic after Hope & Gorob estimate

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
11 Oct 2023 14:53

Faron Pharmaceuticals upbeat on latest data in blood cancer trials

(Sharecast News) - Faron Pharmaceuticals announced encouraging updated data from its ongoing phase one and two 'BEXMAB' study into relapsed or refractory (r/r) acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS) treatments on Wednesday.

Read more
11 Oct 2023 14:01

IN BRIEF: Faron Pharmaceuticals' Bexmarilimab shows 50% remission rate

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical-stage biopharmaceutical company - Says Bexmarilimab study shows 50% remission rate for patients with in relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes. Says eight of eleven patients were complete responders or complete responders with incomplete blood recovery. Adds Bexmarilimab continues to be well-tolerated at all tested dose levels, as no dose-limiting toxicity has been observed.

Read more
21 Sep 2023 14:45

Faron Pharmaceuticals names interim chief medical officer

(Sharecast News) - Cancer immunotherapy-focussed biopharmaceutical firm Faron Pharmaceuticals named Dr Birge Berns as its interim chief medical officer on Thursday, with the transition becoming effective on 22 September, with Dr Berns operating from the UK.

Read more
21 Sep 2023 12:12

TRADING UPDATES: Faron appoints Birge Berns as interim medical officer

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
15 Sep 2023 15:46

UK shareholder meetings calendar - next 7 days

Monday 18 September 
Baillie Gifford US Growth Trust PLCAGM
Inteliqo LtdAGM
LendInvest PLCAGM
Rosslyn Data Technologies PLCGM re fundraise
Tuesday 19 September 
Africa Opportunity Fund LtdAGM
Aston Martin Lagonda Global Holdings PLCGM re supply arrangement with Lucid Group Inc
Augmentum Fintech PLCAGM
Beacon Rise Holdings PLCAGM
Begbies Traynor Group PLCAGM
Chill Brands Group PLCAGM
DP Aircraft I LtdAGM
Great Southern Copper PLCAGM
Manolete Partners PLCAGM
Moonpig Group PLCAGM
Oxford Instruments PLCAGM
ProCook Group PLCAGM
SRT Marine Systems PLCAGM
Unicorn Mineral Resources PLCAGM
Wednesday 20 September 
Accsys Technologies PLCAGM
Frasers Group PLCAGM
Games Workshop Group PLCAGM
Hidong Estate PLCAGM
IG Group Holdings PLCAGM
Ilika PLCAGM
Nippon Active Value Fund PLCGM re assets rollover
Quiz PLCAGM
Seed Innovations LtdAGM
STS Global Income & Growth Trust PLCAGM
Thursday 21 September 
Ascent Resources PLCGM re audited annual accounts
Intercede Group PLCAGM
Kore Potash PLCGM re capital raise
Liontrust Asset Management PLCAGM
Mercia Asset Management PLCAGM
Molecular Energies PLCAGM
Oberon Investments Group PLCAGM
Pelatro PLCGM re AIM cancellation
Sosandar PLCAGM
Thruvision Group PLCAGM
Trakm8 Holdings PLCAGM
Van Elle Holdings PLCAGM
Friday 22 September 
Argos Resources LtdGM re members voluntary liquidation
B&M European Value Retail SAGM re appointing Lasry as director
Faron Pharmaceuticals LtdEGM re election of new board members
Stranger Holdings PLCAGM
SysGroup PLCAGM
TI Fluid Systems PLCGM re waiver resolution
Odyssean Investment Trust PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
5 Sep 2023 14:22

Evgen Pharma hires interim CFO from Faron, chair to retire this month

(Alliance News) - Evgen Pharma on Tuesday said Non-Executive Chair Barry Clare will retire at its next board meeting, and announced the hiring of interim Chief Financial Officer Toni Hanninen.

Read more
29 Aug 2023 10:23

AIM WINNERS & LOSERS: Pelatro plummets on delisting plans

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
29 Aug 2023 10:15

Faron shares surge on FDA drug designation; loss widens on costs

(Alliance News) - Faron Pharmaceuticals Ltd on Tuesday said its interim loss widened on higher costs but saw shares soar after it gained a US Food & Drug Administration orphan drug designation for Bexmarilimab.

Read more
22 Aug 2023 15:46

UK earnings, trading statements calendar - next 7 days

Wednesday 23 August 
Angling Direct PLCTrading Statement
Costain Group PLCHalf Year Results
Thursday 24 August 
Benchmark Holdings PLCQ3 Results
CRH PLCHalf Year Results
Harbour Energy PLCHalf Year Results
Hays PLCFull Year Results
Hunting PLCHalf Year Results
James Cropper PLCHalf Year Results
Macfarlane Group PLCHalf Year Results
Princess Private Equity Holding LtdHalf Year Results
Redcentric PLCFull Year Results
South32 LtdFull Year Results
Tribal Group PLCHalf Year Results
Friday 25 August 
no events scheduled 
Monday 28 August 
no events scheduled 
Tuesday 29 August 
Amaroq Minerals LtdHalf Year Results
Bunzl PLCHalf Year Results
Dalata Hotel Group PLCHalf Year Results
Faron Pharmaceuticals LtdHalf Year Results
PureTech Health PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
19 Jul 2023 10:27

Faron Pharmaceuticals sees positive data from phase 1 BEXMAB trial

(Alliance News) - Faron Pharmaceuticals Ltd on Wednesday said data from its phase 1 BEXMAB study has shown positive data.

Read more
29 Jun 2023 18:55

TRADING UPDATES: Ecofin US Renewables expects to pay reduced dividend

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:

Read more
9 Jun 2023 14:34

TRADING UPDATES: Medica shareholders back takeover; Arecor optimistic

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Friday and not separately reported by Alliance News:

Read more
24 Apr 2023 14:21

Faron Pharmaceuticals test data shows efficacy of bexmarilimab

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said further data from its Phase I/II MATINS study of bexmarilimab has indicated the efficacy and safety of the immunotherapy in solid tumours.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.